ÖÐÊàÉñ¾ÏµÍ³±¬·¢Ñ¬È¾¡¢ÃâÒßÒì³£»òÑ×ÐÔËðÉËʱ£¬»¼Õß¿ÉÄÜ·ºÆð·¢ÈÈ¡¢Í·Í´¡¢ñ²ðï¡¢¾«ÉñÐÐΪÒì³£¡¢ÒâʶÕϰ¡¢ÊÓÁ¦Ï½µ»òÖ«ÌåÎÞÁ¦µÈÌåÏÖ¡£²¿·Ö¼²²¡Æð²¡¼±¡¢Ï£Íû¿ì£¬Èçδʵʱʶ±ðÑ×֢״̬ºÍ²¡ÒòÆ«Ïò£¬¿ÉÄÜÓ°ÏìºóÐøÖÎÁÆÑ¡Ôñ¼°»¼ÕßÔ¤ºó¡£
ÏàËÆµÄÁÙ´²ÌåÏÖ±³ºó£¬¿ÉÄÜÊDz¡¶¾¡¢Ï¸¾ú¡¢½áºË»òÕæ¾úѬȾ£¬Ò²¿ÉÄÜÊÇ×ÔÉíÃâÒßÐÔÄÔÑס¢Ñ×ÐÔÍÑËèÇʼ²²¡»òÖ×ÁöÏà¹Ø¼²²¡¡£ÓÉÓÚ²î±ð¼²²¡ÔçÆÚÖ¢×´±£´æÖصþ£¬½öƾÁÙ´²ÌåÏÖÍùÍùÄÑÒÔʵʱÅжϲ¡Òò¡£
ÖÐÊàÉñ¾ÏµÍ³Ñ×֢״̬ÆÀ¹ÀÊǼ²²¡ÕïÁÆÀú³ÌÖеÄÖ÷Òª»·½Ú£¬µ«²»¿ÉÒÀÀµ¼òµ¥Ö¸±êÍê³É¡£ÁÙ´²Í¨³£ÐèҪ͎áÄÔ¼¹ÒºÍ¨Àý¡¢Éú»¯¡¢Ï¸°ûѧ¡¢²¡Ôѧ¡¢Éñ¾×ÔÉí¿¹Ìå¡¢Ó°Ïñѧ¼°ÄÔµçͼµÈЧ¹û¾ÙÐÐ×ÛºÏÅжϡ£²¿·Ö»¼Õß²¡ÔÌå»òÌØÒìÐÔ¿¹ÌåÔÝʱÄÑÒÔ¼ì³ö£¬Í¨ÀýÖ¸±ê¶Ô¾Ö²¿ÃâÒß¼¤»îÇ¿¶È¼°¶¯Ì¬×ª±äµÄ·´Ó¦Ò²Ïà¶ÔÓÐÏÞ¡£
ÄÔ¼¹ÒºÏ¸°ûÒò×ÓÒÑÔÚÖÐÊàѬȾ¡¢Éñ¾ÃâÒß¼°Ö×ÁöÏà¹Ø¼²²¡ÖлñµÃÒ»Á¬Ñо¿¡£ÎªÔö²¹ÁÙ´²¶ÔÖÐÊà¾Ö²¿Ñ×֢״̬µÄÆÀ¹À£¬×ðÁú¿Ê±ÉÏÏßÄÔ¼¹ÒºÏ¸°ûÒò×Ó¼ì²â·þÎñ£¬Í¨¹ý¶àÖ¸±êÍŽá¼ì²â£¬¸¨Öúʶ±ðÖÐÊàÑ×Ö¢Ðźš¢ÆÀ¹ÀÑ×Ö¢Ô˶¯Ë®Æ½ºÍÃâÒß·´Ó¦ÌØÕ÷£¬ÎªºóÐø²¡ÒòÅŲ鼰²¡Çé¼à²âÌṩʵÑéÊҲο¼¡£

£¨¸ÃͼƬÓÉAIÌìÉú£©
¹ØÓÚÄÔ¼¹ÒºÏ¸°ûÒò×Ó
ϸ°ûÒò×ÓÊÇÃâÒßϸ°ûÖ®¼äת´ïÐÅÏ¢µÄÖ÷ÒªÐźŷÖ×Ó¡£µ±ÖÐÊàÉñ¾ÏµÍ³±¬·¢Ñ¬È¾¡¢ÃâÒßÒì³£»ò×éÖ¯ËðÉËʱ£¬Ð¡½ºÖÊϸ°û¡¢ÐÇÐνºÖÊϸ°ûÒÔ¼°½øÈëÖÐÊàµÄÃâÒßϸ°û»áÊͷŲî±ðÐźţºÓÐЩÈÏÕæÆô¶¯ºÍ·Å´óÑ×Ö¢£¬ÓÐЩÈÏÕæÕÙļ¸ü¶àÃâÒßϸ°û£¬ÉÐÓÐһЩÈÏÕæÒÖÖÆ»òµ÷ÀíÑ×Ö¢¡£¶àÖÖÐźÅÏ໥ӰÏ죬ÅäºÏÐγÉһֱת±äµÄÑ×Ö¢ÍøÂç¡£
³£¼ûϸ°ûÒò×Ó»®·Ö´ú±íʲô£¿
IL-6¡¢TNF-¦Á¡¢IL-1¦Â£º³£¼û´ÙÑ×ÐźÅ
IL-8£º¼ÓÈëÖÐÐÔÁ£Ï¸°ûÕÙļ
IFN-¦Ã¡¢IL-17£º·´Ó¦²î±ðÀàÐ͵Äϸ°ûÃâÒß·´Ó¦
IL-10¡¢IL-4£ºÓ뿹Ñ×»òÃâÒßµ÷ÀíÏà¹Ø
IFN-¦Á£ºÓ뿹²¡¶¾¼°¢ñÐÍ×ÌÈÅËØÍ¨Â·Ïà¹Ø
¿ÉÊÇ£¬ÍâÖÜѪÓëÄÔ¼¹ÒºÑ×Ö¢±ê¼ÇÎïµÄ×ÜÌåÏà¹ØÐԽϵͣ¬ÌáÐÑÁ½ÀàÑù±¾Ëù·´Ó¦µÄÐÅÏ¢±£´æ²î±ð£¬²»¿É¼òÆÓÏà»¥Ìæ»»[1]¡£Ïà½ÏÓÚÒ×ÊÜÈ«ÉíѬȾ¡¢»ù´¡¼²²¡¼°Ò©ÎïµÈÒòËØÓ°ÏìµÄÍâÖÜѪ£¬ÄÔ¼¹Òº¸ü¿¿½üÖÐÊàÉñ¾ÏµÍ³¾Ö²¿ÇéÐΡ£
ÄÔ¼¹ÒºÏ¸°ûÒò×Ó¿ÉΪÊÓ²ìÖÐÊà¾Ö²¿ÃâÒß¼¤»î¡¢Ñ×Ö¢Ô˶¯Ë®Æ½¼°¶¯Ì¬×ª±äÌṩÔö²¹ÐÅÏ¢¡£Ñо¿ÏÔʾ£¬²î±ðÖÐÊàÉñ¾ÏµÍ³Ñ×ÐÔ¼²²¡¿É·ºÆð²î±ðµÄÄÔ¼¹ÒºÏ¸°ûÒò×Ó¼°ÃâÒßϸ°ûÌØÕ÷£¬²¿·Öϸ°ûÒò×Ó»¹¿ÉÄÜÓëÇÊÄÚÑ×Ö¢Ô˶¯×´Ì¬Ïà¹Ø[2-3]¡£
Ñо¿ÏÔʾ£¬ÔÚ¼±ÐÔ²¥É¢ÐÔÄÔ¼¹ËèÑ×£¨Ñ×ÐÔÍÑËèÇʼ²²¡£©¡¢¿¹NMDARÄÔÑ×£¨×ÔÉíÃâÒßÐÔÄÔÑ×£©¼°³¦µÀ²¡¶¾ÐÔÄÔÑ×£¨Ñ¬È¾ÐÔÄÔÑ×£©µÈ´¦ÓÚÔ˶¯ÆÚµÄÖÐÊàÉñ¾ÏµÍ³Ñ×ÐÔ¼²²¡ÖУ¬¶àÖÖÄÔ¼¹ÒºÏ¸°ûÒò×Ó¿ÉÄÜÉý¸ß£¨Í¼1£©¡£

ͼ1. ²î±ð²¡Òò¶ùͯ¼±ÐÔÄÔÑ×ÄÔ¼¹ÒºÏ¸°ûÒò×ÓˮƽµÄ½ÏÁ¿ÆÊÎö[2]
Èý¾ä»°£¬¶Á¶®ÄÔ¼¹ÒºÏ¸°ûÒò×ӵļì²â¼ÛÖµ
¿´Ñ×Ö¢£ºÊÇ·ñ±£´æÖÐÊàÃâÒß¼¤»î£¿
µ±ÁÙ´²Ö¢×´ÌáÐÑÖÐÊàÉñ¾ÏµÍ³Ñ×Ö¢£¬µ«ÔçÆÚÓ°Ïñѧ¡¢ÄÔ¼¹ÒºÍ¨Àý»òÉú»¯Ð§¹û²»µä·¶£¬»ò²¡Ôѧ¡¢×ÔÉí¿¹Ìå¼ì²âÔÝδ»ñµÃÃ÷ȷЧ¹ûʱ£¬ÄÔ¼¹ÒºÏ¸°ûÒò×Ó¼ì²â¿É´Ó´ÙÑס¢¿¹Ñ×¼°ÃâÒßµ÷ÀíµÈά¶È£¬Ôö²¹ÖÐÊà¾Ö²¿ÃâÒß¼¤»îºÍÑ×֢״̬ÐÅÏ¢[2-3]¡£
ÀýÈ磬¹ØÓÚÁÙ´²¸ß¶ÈÒÉËÆ×ÔÉíÃâÒßÐÔÄÔÑ×µ«Éñ¾×ÔÉí¿¹ÌåÒõÐԵϼÕߣ¬Ï¸°ûÒò×ÓÒì³£¿ÉΪÊÇ·ñ±£´æÇÊÄÚÑ×Ö¢·´Ó¦ÌṩÔö²¹ÏßË÷£¬²¢ÍŽáÁÙ´²ÌåÏÖ¡¢ÄÔµçͼ¡¢Ó°Ïñѧ¼°ÆäËûÄÔ¼¹Òº¼ì²éЧ¹û£¬ÎªºóÐø²¡ÒòÅŲéºÍ×ÛºÏÅжÏÌṩ²Î¿¼¡£
ÅÐÔ˶¯£ºÑ×֢ǿ²»Ç¿£¬ÊÇ·ñ±¬·¢×ª±ä£¿
ÄÔ¼¹ÒºÏ¸°ûÒò×ӿɶ¨Á¿¼ì²â¡£Ïàͬƽ̨¡¢×éºÏ¼°Ïà½ü²ÉÑùÌõ¼þϸ´²é£¬¿ÉÊÓ²ìÑ×Ö¢ÐźÅת±ä¡£²¿·ÖÖ¸±ê¿ÉÄÜÓëÔ˶¯ÐÔÇÊÄÚÑ×Ö¢Ïà¹Ø[2]¡£
KothurµÈ¶Ô43Àý¼±ÐÔ²¥É¢ÐÔÄÔ¼¹ËèÑס¢¿¹NMDARÄÔÑ×¼°³¦µÀ²¡¶¾ÐÔÄÔÑ×»¼¶ùµÄÖÎÁÆÇ°ÄÔ¼¹Òº¾ÙÐжàÒò×Ó¼ì²â£¬·¢Ã÷TNF-¦Á¡¢IL-10¡¢IFN-¦ÁºÍIL-6µÈÖ¸±êÔÚ´ó¶¼Ô˶¯ÐÔ²¡ÀýÖÐÉý¸ß¡£ÔÚ3Àý¸´·¢ÐÔÄÔÑײ¡ÀýÖУ¬IFN-¦Á¾ùÔÙ´ÎÉý¸ß£¬²¿·Ö²¡Àýͬʱ·ºÆðÆäËûÇ÷»¯Òò×ÓÉý¸ß[2]¡£ÁíÒ»Ïî¶Ô9Àý¿¹NMDARÄÔÑ×»¼ÕßµÄ27·ÝÄÔ¼¹ÒºÓëѪÇåÅä¶ÔÑù±¾¾ÙÐÐ×ÝÏòÑо¿ÏÔʾ£¬ÄÔ¼¹ÒºIFN-¦Ã¡¢TNF-¦ÁºÍIL-17AÔÚ²¡³Ì²î±ð½×¶ÎÈÔ¿Éά³Ö½Ï¸ßˮƽ[4]¡£ÕâЩÑо¿ÌáÐÑ£¬ÄÔ¼¹ÒºÏ¸°ûÒò×ӿɸ¨ÖúÊÓ²ìÇÊÄÚÑ×Ö¢ÐźŵÄת±äÇ÷ÊÆ¡£
±æ²¡Òò£ºÎª²¡ÒòÆ«ÏòÌṩÔö²¹ÏßË÷
ѬȾ¡¢×ÔÉíÃâÒß¼°Ö×ÁöÏà¹Ø¼²²¡¿ÉÄÜ·ºÆð²î±ðµÄϸ°ûÒò×Ó×éºÏ£¬µ«²î±ð¼²²¡Ö®¼äÈÔ±£´æÏÔ×ÅÖØµþ¡£Ï¸°ûÒò×ÓÆ×¿É·´Ó¦Ñ×֢ǿ¶ÈºÍÃâÒß¼¤»îÆ«Ïò£¬×ÊÖú°²ÅźóÐø¼ì²é¡£
²î±ðÖÐÊàÉñ¾ÏµÍ³Ñ×ÐÔ¼²²¡¿ÉÄÜ·ºÆð²î±ð»¯µÄϸ°ûÒò×Ó×éºÏ£¬µ«¼²²¡Ö®¼ä±£´æÏÔ×ÅÖØµþ¡£KothurµÈ·¢Ã÷£¬¼±ÐÔ²¥É¢ÐÔÄÔ¼¹ËèÑ×»¼Õ߿ɷºÆð¸üÆÕ±éµÄTh2¡¢Th17Ïà¹ØÏ¸°ûÒò×ÓÉý¸ß£»¶ø³¦µÀ²¡¶¾ÐÔÄÔÑ×Ó뿹NMDARÄÔÑ×Ö®¼ä£¬´ó¶¼µ¥Ïîϸ°ûÒò×Óˮƽ²¢ÎÞÏÔÖø²î±ð£¬µ«¶àÒò×Ó¾ÛÀàģʽ¿ÉÄÜÓÐËù²î±ð[2]¡£MichaelµÈ½ÏÁ¿Ñ¬È¾ÐÔÄÔÑס¢ÃâÒ߽鵼ÐÔÄÔÑ×¼°²¡ÒòδÃ÷ÄÔÑ×»¼Õߺó·¢Ã÷£¬²î±ð²¡Òò×éÖ®¼ä½ö²¿·Öϸ°ûÒò×ÓºÍÇ÷»¯Òò×Ó±£´æ²î±ð£¬¼òµ¥Ö¸±êÄÑÒÔ×¼È·Çø·Ö¼²²¡ÀàÐÍ[5]¡£
Òò´Ë£¬ÄÔ¼¹ÒºÏ¸°ûÒò×ӯ׏üÊÊÊÊÓÃÓÚÌáÐÑÑ×Ö¢·´Ó¦Ç¿¶ÈºÍÃâÒß¼¤»îÆ«Ïò£¬×ÊÖúÁÙ´²È·¶¨ºóÐø²¡Ôѧ¡¢Éñ¾×ÔÉí¿¹Ìå¡¢Ó°Ïñѧ»òÖ×ÁöÏà¹Ø¼ì²éµÄÓÅÏȼ¶¡£

ÄÄЩÁÙ´²³¡¾°ÖµµÃ¹Ø×¢£¿
Ò»¡¢ÒÉËÆÖÐÊàÉñ¾ÏµÍ³Ñ¬È¾
¹ØÓÚ·ºÆð·¢ÈÈ¡¢Í·Í´¡¢ÄÔĤ´Ì¼¤Õ÷¡¢ÒâʶÕϰ»òñ²ðïµÈÌåÏֵϼÕߣ¬Ó¦ÍŽáÄÔ¼¹ÒºÍ¨Àý¡¢Éú»¯¡¢Í¿Æ¬Óë×÷Óý¡¢²¡ÔºËËá¼ì²â¼°ºê»ùÒò×é²âÐòµÈ¼ì²éѰÕÒѬȾ֤¾Ý¡£Ñо¿ÏÔʾ£¬IL-6¡¢IL-8¡¢TNF-¦Á¡¢IFN-¦ÃµÈϸ°ûÒò×ÓÔÚ²î±ðÀàÐ͵ÄÖÐÊàÉñ¾ÏµÍ³Ñ¬È¾ÖпÉÄÜ·ºÆð²î±ð£¬²¿·ÖÖ¸±ê¶Ôϸ¾úÐÔ¡¢²¡¶¾ÐÔ¼°½áºËÐÔÄÔĤÑ׵ĸ¨ÖúÅбð¾ßÓÐÑо¿¼ÛÖµ¡£
ÄÔ¼¹ÒºÏ¸°ûÒò×Ó¼ì²â¿ÉÔÚ²¡Ôѧ¼ì²é»ù´¡ÉÏ£¬Ôö²¹ÊӲ죺
ÊÇ·ñ±£´æÏÔ×ŵÄÖÐÊà¾Ö²¿Ñ×Ö¢·´Ó¦
Ä¿½ñÑ×Ö¢·´Ó¦µÄÇ¿¶È¼°ÃâÒß¼¤»îÌØÕ÷
ÖÎÁÆÇ°ºóÑ×Ö¢ÐźŵĶ¯Ì¬×ª±ä
ϸ°ûÒò×ÓÉý¸ß×Ô¼º²»¿ÉÖ±½ÓÈ·¶¨Ñ¬È¾²¡Ô»òѬȾÀàÐÍ£¬ÁÙ´²Ú¹ÊÍÐèÍŽáÄÔ¼¹ÒºÏ¸°ûÊý¼°·ÖÀà¡¢ÂѰ׺ÍÌÇˮƽ¡¢²¡ÔѧЧ¹û¡¢Ó°ÏñѧÌåÏÖ¼°»¼ÕßÖÎÁÆ·´Ó¦¾ÙÐÐ×ÛºÏÅжϡ£
¶þ¡¢ÒÉËÆ×ÔÉíÃâÒßÐÔÄÔÑ×»òÑ×ÐÔÍÑËèÇʼ²²¡
µ±»¼Õß·ºÆð¾«ÉñÐÐΪÒì³£¡¢ÈÏ֪Ͻµ¡¢ñ²ðï¡¢ÊÓÁ¦Ï½µ¡¢Ö«ÌåÎÞÁ¦»ò¼¹ËèÑ×ÑùÌåÏÖʱ£¬ÐèÒª¹Ø×¢×ÔÉíÃâÒßÐÔÄÔÑס¢NMOSD¡¢¶à·¢ÐÔÓ²»¯¡¢MOGADµÈÉñ¾ÃâÒßÐÔ¼²²¡¡£GrausµÈÌá³ö£¬×ÔÉíÃâÒßÐÔÄÔÑ×µÄÕï¶ÏÓ¦×ÛºÏÁÙ´²ÌåÏÖ¡¢ÄÔ¼¹Òº¼ì²é¡¢MRI¡¢ÄÔµçͼ¡¢Éñ¾×ÔÉí¿¹Ìå¼ì²â¼°ÆäËû²¡Òòɨ³ýЧ¹û[6]¡£
Ñо¿ÏÔʾ£¬NMOSD¡¢¶à·¢ÐÔÓ²»¯µÈ¼²²¡¿É·ºÆð²î±ðµÄÄÔ¼¹ÒºÏ¸°ûÒò×Ó»òÇ÷»¯Òò×ÓÌØÕ÷£¬IL-6¡¢IL-10¼°IL-17Ïà¹ØÍ¨Â·¿ÉÄܼÓÈë¼²²¡±¬·¢Éú³¤[7-9]¡£ÄÔ¼¹ÒºÏ¸°ûÒò×Ó¿ÉÔö²¹ÊÓ²ìÇÊÄÚÃâÒß¼¤»î¼°Ñ×Ö¢Ô˶¯×´Ì¬£¬ÓÈÆäÊÊÓÃÓÚÁÙ´²¸ß¶ÈÏÓÒÉÉñ¾ÃâÒßÐÔ¼²²¡£¬µ«×ÔÉí¿¹ÌåÒõÐÔ¡¢Ó°Ïñѧ»òͨÀýÄÔ¼¹ÒºÐ§¹û²»µä·¶µÄ»¼Õß¡£
Ïà¹ØÐ§¹ûÓ¦ÓëÉñ¾×ÔÉí¿¹Ìå¡¢¹Ñ¿ËÂ¡Çø´ø¡¢IgGÖ¸Êý¡¢ÄÔ¼¹ÒºÏ¸°ûѧ¡¢MRI¼°ÄÔµçͼµÈÍŽá½â¶Á¡£²î±ð¼²²¡Ö®¼äµÄϸ°ûÒò×ÓÆ×¿ÉÄܱ£´æÖصþ£¬¼òµ¥Ö¸±ê»òµ¥´Î¼ì²âЧ¹û²»¿É×ÔÁ¦ÓÃÓÚ¼²²¡È·Õï»ò·ÖÐÍ¡£
Èý¡¢Ö×ÁöÏà¹Ø»òÔµ¹ÊÔÓɲ»Ã÷µÄÖÐÊàÑ×Ö¢
²¿·ÖÖÐÊàÉñ¾ÏµÍ³Ö×Áö¿ÉÅãͬÏà¶ÔÌØÕ÷ÐÔµÄÄÔ¼¹ÒºÏ¸°ûÒò×Óת±ä¡£Ñо¿ÏÔʾ£¬ÄÔ¼¹ÒºIL-10¼°IL-10/IL-6±ÈÖµÔÚÔ·¢ÐÔÖÐÊàÉñ¾ÏµÍ³´óBϸ°ûÁܰÍÁöµÄ¸¨ÖúÅбðÖоßÓÐDZÔÚ¼ÛÖµ[10-11]¡£¹ØÓÚÏÓÒÉÔ·¢ÐÔÖÐÊàÉñ¾Ï½µµÍܰÍÁöµÄ»¼Õߣ¬Ï¸°ûÒò×Ó¼ì²â¿ÉÓëÔöÇ¿MRI¡¢ÄÔ¼¹ÒºÏ¸°ûѧ¡¢Á÷ʽϸ°ûÊõ¡¢ÃâÒßÇòÂѰ׻ùÒòÖØÅż°×éÖ¯²¡ÀíѧµÈ¼ì²éÍŽáÓ¦Óã¬ÎªºóÐø¼ì²éÆ«ÏòÌṩÔö²¹ÒÀ¾Ý¡£IL-10Éý¸ß»òIL-10/IL-6±ÈÖµÒì³£ÌáÐÑÐèÒª½øÒ»²½¹Ø×¢Ö×ÁöÏà¹Ø¿ÉÄÜ£Û10£Ý£¬ÈÔÐèͨ¹ýÓ°Ïñ¡¢Ï¸°ûѧ¡¢·Ö×Ó¼ì²â»ò²¡ÀíЧ¹û¾ÙÐÐÑéÖ¤¡£
SasayamaµÈ±¨µÀÁËÒ»ÀýÔ·¢ÐÔÖÐÊàÉñ¾Ï½µµÍܰÍÁö£¨PCNSL£©»¼Õߣ¬ÄÔ¼¹ÒºIL-10ºÍIL-6Ë®Æ½ËæÖ×Áö¸ººÉת±ä¶øÍ¬²½²¨¶¯¡£ÖÎÁÆÇ°£¬MRIÏÔʾÓÒÕíÒ¶¼°ëÝëÕÌ岡ÔîÏ£Íû£¬ÄÔ¼¹ÒºIL-10ºÍIL-6»®·ÖΪ1090 pg/mLºÍ16.2 pg/mL£¨Í¼2A£©£»3ÖܺóÖ×Áöδ¾ÖÎÁÆ×Ô¾õËõС£¬Á½Õß½µÖÁ113 pg/mLºÍ2.8 pg/mL£¨Í¼2B£©£»ËæºóÖ×ÁöÓÚË«²à¶îÒ¶¸´·¢£¬IL-10ºÍIL-6ÔÙ´ÎÉýÖÁ675 pg/mLºÍ8.3 pg/mL£¨Í¼2C£©£»¾·Å»¯ÁƵִïÍêÈ«»º½âºó£¬»®·Ö½µÖÁ£¼2 pg/mLºÍ1.3 pg/mL£¨Í¼2D£©¡£¸Ã²¡ÀýÌáÐÑ£¬ÄÔ¼¹ÒºIL-10ºÍIL-6ˮƽ¿ÉÄÜÓëÖ×ÁöÔ˶¯¼°ÖÎÁÆ·´Ó¦Ïà¹Ø¡£

ͼ2. PCNSL»¼ÕßÄÔ¼¹ÒºIL-10ºÍIL-6ËæÖ×Áö¸ººÉ¼°ÖÎÁÆ·´Ó¦µÄ¶¯Ì¬×ª±ä£Û10£Ý
7ÏîÓë12ÏîË«×éºÏ£¬Æ¥Åä²î±ðÖÐÊàÑ×Ö¢ÆÀ¹ÀÐèÇó
ÖÐÊàÑ×Ö¢¿ÉÄÜÉæ¼°´ÙÑס¢¿¹Ñס¢Ï¸°ûÃâÒß¡¢ÖÐÐÔÁ£Ï¸°ûÇ÷»¯¡¢Th2/ÊÈËáÐÔÁ£Ï¸°û·´Ó¦¼°¢ñÐÍ×ÌÈÅËØµÈ¶àÌõͨ·¡£×ðÁú¿Ê±ÍƳöµÄÄÔ¼¹ÒºÏ¸°ûÒò×Ó¼ì²â·þÎñ£¬Æ¾Ö¤²î±ðµÄÁÙ´²ÆÀ¹ÀÐèÇó£¬ÉèÖÃ7Ïî»ù´¡×éºÏºÍ12ÏîÀ©Õ¹×éºÏ£¬¼æ¹Ë»ù´¡Ñ×֢״̬ÊÓ²ìºÍ¸üÍêÕûµÄÃâÒßÑ×Ö¢Æ×ÆÀ¹À¡£

×ðÁú¿Ê±Ò»Á¬Éî¸ûÉñ¾¼²²¡¼ì²âÁìÓò£¬Ï¸ÃÜÎ§ÈÆÁÙ´²ÕïÁÆÐèÇó£¬Ò»Ö±ÍêÉÆÁýÕÖѬȾ¡¢Éñ¾ÃâÒß¡¢Éñ¾ÍËÐÐÐÔ¼²²¡¼°ÄÔѪ¹Ü²¡µÈÆ«ÏòµÄ¼ì²â·þÎñϵͳ¡£Î´À´£¬×ðÁú¿Ê±½«ÒÀÍжàÊÖÒÕÆ½Ì¨Óëרҵҽѧ·þÎñÄÜÁ¦£¬Ò»Á¬¿ª·¢Ô½·¢¾«×¼¡¢ÏµÍ³¡¢Ìù½üÁÙ´²³¡¾°µÄ¼ì²â²úÆ·£¬ÎªÖÐÊàÉñ¾ÏµÍ³¼²²¡µÄ²¡ÒòÅб𡢲¡ÇéÆÀ¹À¡¢ÁÆÐ§¼à²â¼°¿ÆÑÐת»¯Ìṩ¸ü¶àʵÑéÊÒÖ§³Ö£¬ÓëÁÙ´²×¨¼ÒÅäºÏÍÆ¶¯Éñ¾¼²²¡¾«×¼ÕïÁÆÄÜÁ¦µÄÌáÉý¡£
²Î¿¼ÎÄÏ×
£Û1£ÝGigase, F. A. J., et al. (2023). The Association Between Inflammatory Markers in Blood and Cerebrospinal Fluid: A Systematic Review and Meta-Analysis. Molecular Psychiatry, 28(4), 1502-1515.
£Û2£ÝKothur, K., et al. (2016). Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis. PLOS ONE, 11(8), e0161656.
£Û3£ÝLepennetier, G., et al. (2019). Cytokine and Immune Cell Profiling in the Cerebrospinal Fluid of Patients With Neuro-Inflammatory Diseases. Journal of Neuroinflammation, 16, 219.
£Û4£ÝLiba, Z., et al. (2016). Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid. Journal of Neuroinflammation, 13, 55. doi:10.1186/s12974-016-0507-9.
£Û5£ÝMichael, B. D., et al. (2016). Characteristic Cytokine and Chemokine Profiles in Encephalitis of Infectious, Immune-Mediated, and Unknown Aetiology. PLOS ONE, 11(1), e0146288. doi:10.1371/journal.pone.0146288.
£Û6£ÝGraus, F., et al. (2016). A Clinical Approach to Diagnosis of Autoimmune Encephalitis. The Lancet Neurology, 15(4), 391-404.
£Û7£ÝUzawa, A., et al. (2014). Cytokines and Chemokines in Neuromyelitis Optica: Pathogenetic and Therapeutic Implications. Brain Pathology, 24(1), 67-73.
£Û8£ÝMatsushita, T., et al. (2013). Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis. PLOS ONE, 8(4), e61835.
£Û9£ÝBai, Z., et al. (2019). Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients. Frontiers in Neuroscience, 13, 1026.
£Û10£ÝSasayama, T., et al. (2012). Cerebrospinal Fluid Interleukin-10 Is a Potentially Useful Biomarker in Immunocompetent Primary Central Nervous System Lymphoma (PCNSL). Neuro-Oncology, 14(3), 368-380.
£Û11£ÝSong, Y., et al. (2016). Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-Cell Lymphoma. Scientific Reports, 6, 38671.